Search Within

Immunology Program Faculty

  1. "Katherine Panageas"
Formats
  1. Journal Article (28)
  2. Meeting Abstract (5)
Groups
  1. Biostatistics Service (33)
  2. Epidemiology and Biostatistics (33)
  3. Population Sciences Research Program (33)
  4. Sloan Kettering Institute Faculty (33)
  5. Department of Medicine (30)
  6. Solid Tumor Oncology Division (26)

More Groups

People
  1. Katherine Panageas (33)
  2. Alan Houghton (29)
  3. Paul Chapman (17)
  4. Jedd Wolchok (16)
  5. Philip Livingston (13)
  6. Jianda Yuan (10)

More People

Years
  1. 2023 (1)
  2. 2018 (1)
  3. 2017 (1)
  4. 2013 (1)
  5. 2011 (1)
  6. 2010 (2)

More Years

Publications
  1. Clinical Cancer Research (5)
  2. Journal of Clinical Oncology (4)
  3. Cancer (3)
  4. Cancer Research (2)
  5. Cytotherapy (2)
  6. Molecular Therapy (2)

More Publications

Publishers
  1. American Association for Cancer Research (9)
  2. American Society of Clinical Oncology (4)
  3. Nature Publishing Group (3)
  4. Wiley Blackwell (3)
  5. Elsevier Science Ltd. (2)
  6. Academy of Cancer Immunology (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Blockade of surface-bound TGF-ß on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
    Journal Article

    Budhu, S.; Schaer, D. A.; Li, Y.; Toledo-Crow, R.; Panageas, K.; Yang, X.; Zhong, H.; Houghton, A. N.; Silverstein, S. C.; Merghoub, T.; more...
    Science Signaling (2017)

    Fulltext@MSK | Save
  • Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Adamow, M.; Mu, Z.; Tandon, S.; Hannaman, D.; Chapman, P.; Schwartz, G.; Carvajal, R.; Panageas, K. S.; more...
    Journal for ImmunoTherapy of Cancer (2013)

    Fulltext@MSK | Save
  • Peptide-loaded langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo
    Journal Article

    Romano, E.; Rossi, M.; Ratzinger, G.; De Cos, M. A.; Chung, D. J.; Panageas, K. S.; Wolchok, J. D.; Houghton, A. N.; Chapman, P. B.; Heller, G.; more...
    Clinical Cancer Research (2011)

    Fulltext@MSK | Save
  • Cyclophosphamide enhances immunity by modulating the balance of dendritic cell subsets in lymphoid organs
    Journal Article

    Nakahara, T.; Uchi, H.; Lesokhin, A. M.; Avogadri, F.; Rizzuto, G. A.; Hirschhorn-Cymerman, D.; Panageas, K. S.; Merghoub, T.; Wolchok, J. D.; Houghton, A. N.
    Blood (2010)

    Fulltext@MSK | Save
  • Immunologic response to xenogeneic gp100 DNA in melanoma patients: Comparison of particle-mediated epidermal delivery with intramuscular injection
    Journal Article

    Ginsberg, B. A.; Gallardo, H. F.; Rasalan, T. S.; Adamow, M.; Mu, Z.; Tandon, S.; Bewkes, B. B.; Roman, R. A.; Chapman, P. B.; Schwartz, G. K.; more...
    Clinical Cancer Research (2010)

    Fulltext@MSK | Save
  • Safety and immunogenicity of gp100 DNA vaccines in patients with melanoma
    Meeting Abstract

    Yuan, J.; Ku, G. Y.; Gallardo, H. F.; Orlandi, F.; Manukian, G.; Rasalan, T.; Li, H.; Xu, Y.; Vyas, S.; Mu, Z.; more...
    Cancer Research (2009)

    Fulltext@MSK | Save
  • Safety and immunogenicity of a human and mouse gp100 DNA vaccine in a phase I trial of patients with melanoma
    Journal Article

    Yuan, J.; Ku, G. Y.; Gallardo, H.; Orlandi, F.; Manukian, G.; Rasalan, T.; Xu, Y.; Li, H.; Vyas, S.; Mu, Z.; more...
    Cancer Immunity (2009)

    Fulltext@MSK | Save
  • Self-antigen-specifc CD8(+) T cell precursor frequency determines the quality of the antitumor immune response
    Journal Article

    Rizzuto, G. A.; Merghoub, T.; Hirschhorn-Cymerman, D.; Liu, C.; Lesokhin, A. M.; Sahawneh, D.; Zhong, H.; Panageas, K. S.; Perales, M. A.; Altan-Bonnet, G.; more...
    Journal of Experimental Medicine (2009)

    Fulltext@MSK | Save